Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 16.78% |
| A M R CP | AAMRQ | 7.91% |
| JAZZ PHARMAC | JAZZ | 7.07% |
| SANTARUS INC | SNTS | 6.50% |
| OLD SECOND B | OSBC | 5.64% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
JPMorgan Chase & Co. ( JPM - Analyst Report ) continues to be in sticky waters as litigation issues arising from the sale of mortgage backed securities (MBS) by Bear Stearns & Co. – acquired in 2008 – seem to be never ending. Now, the U.S. regulator for credit unions – National Credit Union Administration (NCUA) – has sued its unit, J.P. Morgan Securities, for misrepresentation in the underwriting and sale of MBS worth over $3.6 billion.
The aforesaid MBS were sold to U.S. Central, Western Corporate, Southwest Corporate and Members United Corporate federal credit unions. Later, these four became insolvent and were placed under NCUA conservatorship and then liquidated due to losses from these risky MBS.
Allegations
JPMorgan has been accused by NCUA of issuing misleading statements and omitting important details from the offering documents of the MBS in question. This led to obscurity regarding the risks associated with the MBS when they were sold.
The credit unions perceived them to be less risky, when in fact, the securities bore substantial risk. Moreover, it has been alleged that JPMorgan has been ignoring the underwriting guidelines specified in the offering documents.
As a result, when these MBS lost their value for defaults in the underlying assets, the value of investments of the credit unions in these MBS plummeted. Subsequently, the four credit unions collapsed, triggering a crisis in the credit union industry.
Similar Charges Earlier
This is the second time that JPMorgan has been sued by NCUA. In June 2011, the company along with Royal Bank of Scotland PLC ( RBS ) was accused of defrauding five large credit unions by selling more than $3 billion worth of high-risk MBS. NCUA seeks to recover about $840 million in losses at five wholesale credit unions through these lawsuits.
Further, many other global giants including Credit Suisse Group ( CS - Snapshot Report ) , Goldman Sachs Group Inc. ( GS - Analyst Report ) , Wells Fargo & Company ( WFC - Analyst Report ) and Barclays PLC ( BCS - Snapshot Report ) are facing similar lawsuits from NCUA. Moreover, to date, NCUA reached settlements with Deutsche Bank AG ( DB - Snapshot Report ) , HSBC Holdings plc ( HBC - Analyst Report ) and Citigroup Inc. ( C - Analyst Report ) worth about $171 million.
Our Viewpoint
Such cases are inevitably going to result in mounting litigation risks for JPMorgan, which pose a menace for both its image as well as financials. On the other hand, recoveries by NCUA would result in lowering of losses that arose from the failure of the credit unions.
Though the overall impact from such lawsuits is yet to be perceived, these measures are somewhat reassuring as they are aimed at resisting malpractices related to selling MBS. Most importantly, such measures would impart much needed transparency to banking procedures at the time of selling MBS.
Currently, JPMorgan retains a Zacks #3 Rank, which translates into a short-term Hold rating. We believe that on account of such litigation overhangs, there is little possibility of any upward estimate revisions; hence, the stock is expected to hold its current rank. We also maintain a long-term ‘Neutral’ recommendation on the stock.
Read the full reports :
Analyst Report on JPM
Snapshot Report on CS
Snapshot Report on BCS
Snapshot Report on DB
Analyst Report on WFC
on RBS
Analyst Report on C
Analyst Report on GS
Analyst Report on HBC